• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Res . Cooperation of immune regulators Tollip and surfactant protein A inhibits influenza A virus infection in mice

tetano

Editor, Senior Moderator
Respir Res


. 2024 May 3;25(1):193.
doi: 10.1186/s12931-024-02820-3. Cooperation of immune regulators Tollip and surfactant protein A inhibits influenza A virus infection in mice

Niccolette Schaunaman[SUP] 1 [/SUP], Diana Cervantes[SUP] 1 [/SUP], Taylor Nichols[SUP] 1 [/SUP], Mari Numata[SUP] 1 [/SUP], Julie G Ledford[SUP] 2 [/SUP], Monica Kraft[SUP] 3 [/SUP], Hong Wei Chu[SUP] 4 [/SUP]



Affiliations
Abstract

Background: Influenza A virus (IAV) infection is a significant risk factor for respiratory diseases, but the host defense mechanisms against IAV remain to be defined. Immune regulators such as surfactant protein A (SP-A) and Toll-interacting protein (Tollip) have been shown to be involved in IAV infection, but whether SP-A and Tollip cooperate in more effective host defense against IAV infection has not been investigated.
Methods: Wild-type (WT), Tollip knockout (KO), SP-A KO, and Tollip/SP-A double KO (dKO) mice were infected with IAV for four days. Lung macrophages were isolated for bulk RNA sequencing. Precision-cut lung slices (PCLS) from WT and dKO mice were pre-treated with SP-A and then infected with IAV for 48 h.
Results: Viral load was significantly increased in bronchoalveolar lavage (BAL) fluid of dKO mice compared to all other strains of mice. dKO mice had significantly less recruitment of neutrophils into the lung compared to Tollip KO mice. SP-A treatment of PCLS enhanced expression of TNF and reduced viral load in dKO mouse lung tissue. Pathway analysis of bulk RNA sequencing data suggests that macrophages from IAV-infected dKO mice reduced expression of genes involved in neutrophil recruitment, IL-17 signaling, and Toll-like receptor signaling.
Conclusions: Our data suggests that both Tollip and SP-A are essential for the lung to exert more effective innate defense against IAV infection.

Keywords: Influenza A virus; Neutrophilic inflammation; Surfactant protein A; Tollip.

 
Back
Top Bottom